BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Net Income (Common)
BRAIN Biotech AG
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Net Income (Common)
€-8.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Net Income (Common)
€313.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
61%
|
|
Evonik Industries AG
XETRA:EVK
|
Net Income (Common)
€-465m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Covestro AG
XETRA:1COV
|
Net Income (Common)
€-198m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Net Income (Common)
€34.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Net Income (Common)
€340.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
See Also
What is BRAIN Biotech AG's Net Income (Common)?
Net Income (Common)
-8.4m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Net Income (Common) amounts to -8.4m EUR.
What is BRAIN Biotech AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%
Over the last year, the Net Income (Common) growth was -24%. The average annual Net Income (Common) growth rates for BRAIN Biotech AG have been 8% over the past three years , 2% over the past five years .